UAM
ARKG icon

UAS Asset Management’s ARK Genomic Revolution ETF ARKG Stock Holding History

UAS Asset Management’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-40,000
Closed -$3.7M – 19
2021
Q2 		$3.7M Buy
40,000
+35,750
+841% +$3.04M 0.91% 9
2021
Q1 		$377K Sell
4,250
-193,900
-98% -$19.2M 0.1% 15
2020
Q4 		$18.5M Buy
198,150
+147,815
+294% +$11.8M 5.21% 7
2020
Q3 		$3.21M Buy
50,335
+260
+0.5% +$15.2K 0.98% 12
2020
Q2 		$2.61M Buy
+50,075
New +$2.15M 0.94% 15
2020
Q1 		– Sell
-70,000
Closed -$2.35M – 24
2019
Q4 		$2.35M Buy
+70,000
New +$2.22M 0.87% 16

Other funds holding ARKG

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

UAS Asset Management's ARKG Position: Q3 2021 in Review

UAS Asset Management sold out of ARK Genomic Revolution ETF (ARKG) in Q3 2021, closing a stake of 40,000 shares — an estimated $3.7M sold.

UAS Asset Management first reported a position in ARKG in Q4 2019 and held it in 6 quarters. The position peaked at $18.5M in Q4 2020. 468 funds tracked by Wall St. Rank hold ARKG as of Q3 2021.

  • UAS Asset Management reported no remaining ARK Genomic Revolution ETF position as of Q3 2021 after selling out during the quarter.
  • UAS Asset Management sold 40,000 ARK Genomic Revolution ETF shares in Q3 2021, an estimated $3.7M.
  • UAS Asset Management first reported a position in ARK Genomic Revolution ETF in Q4 2019 and held it in 6 quarters.
  • UAS Asset Management's ARK Genomic Revolution ETF position peaked at $18.5M in Q4 2020.
  • 468 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q3 2021.

Based on UAS Asset Management's 13F filing for Q3 2021, filed 12 Nov 2021.